Opioid Addiction

Latest

Promotion of Medications for Opioid Use Disorder Aimed at Urban, Not Rural, Prescribers

By

Laurell Haapanen

Researchers looked at data for 18,318 physicians who received opioid use disorder medication promotions, totaling $9.6 million during the study period.

FDA Committees Vote on Novel Opioid for Chronic Low Back Pain

By

Diana Ernst, RPh

As a result of the vote, Nektar has decided to withdraw the New Drug Application for oxycodegol and to cease further development of the product.

Effects of Opioid Agonists on Sleep Quality in Opioid Use Disorder

By

Rita Aghjayan

Patients perception of poor sleep differ from EEG-reported results.

Drop in Opioid Prescribing at ED Discharge Noted in Recent Years

The percentage of emergency department visits with an opioid prescribed increased from 2006-2007 to 2010-2011 then decreased to 2016-2017.

Few Youths Receive Addiction Treatment After Opioid Overdose

Less than one-third of youths surviving an opioid overdose receive timely addiction treatment.

CDC Data May Be Underreporting Scope of Overdose Deaths

Data from the US Centers for Disease Control and Prevention may be underreporting overdose deaths caused by opioids and other drugs.

Prescribing Practices Can Mitigate Opioid Overdose Risk for Teenagers

Older teens may have similar risk factors for prescription opioid overdose as adults.

Overdose, Relapse After Buprenorphine Discontinuation High

Buprenorphine treatment may be needed for several years after an opioid overdose to reduce the risk of overdose and other adverse events.

Prepregnancy Surgery Linked to Risk for Neonatal Abstinence Syndrome

Prescription opioids for postsurgical pain may lead to addiction that affects future pregnancies

Misuse of Nonopioid Medications on the Rise in the United States

Misuse/abuse, use in suicide attempts, and hospital admissions associated with gabapentin and baclofen have significantly increased among U.S. adults since 2013.